The Drug Administration of Vietnam asks manufacturers, exporters, importers and storage-service providers of drugs and drug materials to register at csdlduoc.com.vn and connect their data, while provincial Departments of Health onboard wholesalers and pharmacies. The deadline was 4 October 2026; facilities not yet registered should do so now.
Official Letter 8000/BYT-QLD circulated the draft Decree amending Decree 163/2025/ND-CP to ministries, business associations and pharmaceutical companies. The comment period ended on 2 November 2026. The Ministry of Health will now consolidate comments and finalise the draft for appraisal and submission to the Government; no issue date has been announced.
Decisions 3304, 3307, 3332 and 3410/QD-BYT withdraw the certificates of CPC1 – Ho Chi Minh City Branch, Hoa Duoc Viet Nam, Medochemie (Vien Dong) and Cuu Ton Pharmaceutical. All four were requested by the companies themselves; no violations are cited.
Under Official Letter 3826/QLD-KD, applications to import narcotic, psychotropic and precursor drugs and drug materials (procedures TT-38 and TT-39) can now be filed and processed online at https://dichvucong.dav.gov.vn.
The Ministry of Health has republished the procedures for granting, renewing, changing and withdrawing marketing authorisations for drugs and pharmaceutical starting materials under Circular 32/2026/TT-BYT. Decision 1983/QD-BYT, issued under the former Circular 12/2025/TT-BYT, is repealed.
The Ministry of Health places eight product groups at medium risk: infant and young-child formula products, plastic and rubber food-contact materials, bottled water and ready-to-use ice. The Circular took effect on 1 July 2026.
On 21 October 2026 the Minister of Health presented a bill amending the Pharmacy Law, the Law on Medical Examination and Treatment, the Law on Health Insurance and three social laws. Drug companies would publish expected wholesale prices with their pricing method; medical-device businesses would list and declare prices on a national data system, managed across the product lifecycle. The bill is still under debate — no vote or effective date has been announced.
Medibase now mirrors the public dataset published by Vietnam's Drug Administration (DAV) at dichvucong.dav.gov.vn/congbogiathuoc and adds cross-field indexed search on top. Look up declared wholesale prices or hospital tender-winning prices by active ingredient, registration number, manufacturer or country of origin — with the latest sync date and record count shown on every query.
Issued 29 July 2026 by the Ministry of Health, Circular 32/2026/TT-BYT replaces Circular 12/2025/TT-BYT as the operating rulebook for marketing-authorisation of chemical drugs, vaccines, biologicals, herbal medicines and pharmaceutical materials. Traditional medicine stays under Circular 29/2025. What actually changes, transitional provisions for in-flight dossiers, and what MA holders should do in the next six weeks.
Signed 1 June 2026 by Deputy Minister Nguyen Tri Thuc and effective 16 July 2026, Circular 18/2026/TT-BYT replaces Circular 20/2017 and 27/2024 as the implementing instrument for the Pharmacy Law and Decree 163/2025/ND-CP. Five chapters, nineteen articles, and a same-day reclassification of Etomidate and Carisoprodol as psychotropic substances.
A 69-page operations manual aligned with Prime Minister's Directive 24/CT-TTg (29/7/2024), built on Law on Bidding 22/2023/QH15 (as amended by Law 57/2024 and Law 90/2025), Decree 214/2025/ND-CP and Circular 40/2025/TT-BYT — covering procurement planning, open competitive tender, competitive offer, direct procurement and designation, for entities under the Ministry of Health.
Telemedicine is no longer an exception scheme. From 1 January 2024, Law 15/2023/QH15 codifies it as a regulated form of medical practice; Decree 96/2023/ND-CP and Circular 32/2023/TT-BYT pin the operational conditions; Decision 2628/QD-BYT remains the operational backbone of the inter-facility network; and a data / cybersecurity overlay — Decree 13/2023/ND-CP, Law on Electronic Transactions 2023, Decree 53/2022/ND-CP, Personal Data Protection Law 2025 — applies on top. For a foreign company, the entry path is constrained at three layers: the WTO schedule and Law on Investment 2020 (corporate vehicle), the practising licence and language rule for the doctor, and the data-localisation and consent regime (Decree 13/2023, Personal Data Protection Law). A synthesis of the law text on the Government Portal and ThuVienPhapLuat, the implementing decree and circular, the 2020 telehealth project decision, and analytical coverage from kcb.vn, xaydungchinhsach.chinhphu.vn and LuatVietnam.
From the École de Médecine de l'Indochine founded in Hanoi in 1902 to the ~35+ accredited universities and academies operating today, Vietnam's medical and pharmaceutical training system now spans the historic flagships, regional public universities, the Vietnam Military Medical University and a growing cluster of private schools led by VinUniversity. A synthesis read against Law on Medical Examination and Treatment 2023 (Law 15/2023/QH15), Decree 96/2023/ND-CP, and the National Medical Licensing Exam phasing in from 1 January 2027.
From 1 January 2024, the Law on Medical Examination and Treatment No. 15/2023/QH15 replaced the 2009 law and rewrote the architecture of medical practice. Decree 96/2023/ND-CP and Circular 32/2023/TT-BYT detailed the new conditions for both individual practitioners and establishments. From 1 January 2025 the three-tier system (initial / basic / specialised) replaced the old four-tier scheme, and from 1 July 2026 Resolution 21/2026/NQ-CP delegates practising licence authority from the Ministry of Health to the chairpersons of provincial People's Committees. A synthesis of the law text on the Government Portal and ThuVienPhapLuat, the implementing decree and circular, the delegation resolution, and analysis from kcb.vn, xaydungchinhsach.chinhphu.vn and LuatVietnam.
From 1 July 2025, the amended Pharmacy Law (Law 44/2024/QH15) and the new drug-registration circular (Circular 12/2025/TT-BYT) took effect together, reshaping the operational duties of marketing-authorisation holders, manufacturers, importers and distributors. The 2021 National Pharmacovigilance Guideline (Decision 122/QD-BYT) survives as the technical backbone. A synthesis of the consolidated Pharmacy Law (VBHN 39/VBHN-VPQH / 76/VBHN-VPQH), DAV guidance, and industry analysis from LuatVietnam, ThuVienPhapLuat, the canhgiacduoc.org.vn DI&ADR portal, Lexology and Dione.
Eight years of regulatory practice under Decree 15/2018 have been replaced — section by section — by Decree 46/2026, in force from 15 April 2026 after a 75-day suspension. A deep, area-by-area comparison of what the new framework keeps, narrows, expands, and introduces for the first time.
Livzon's 64.81% takeover of Imexpharm is the largest deal in a longer foreign-acquisition cycle that also touches DHG Pharma, Domesco, Pymepharco, Traphaco, Ha Tay Pharmaceutical, and Trung Son Pharma — shaped by EU-GMP capacity, hospital-tender economics, and Vietnam's foreign-distribution rules.
Signed 26 January 2026 to replace Decree 15/2018, the new food-safety decree triggered a multi-association revolt within ten days, was suspended by Resolution 09/2026/NQ-CP until 15 April 2026, and has now resumed with only partial guidance in place. A synthesis of reporting from VnEconomy, VietnamNet, NLD, baochinhphu.vn, LuatVietnam and the VIB business-impact survey.
